Announcements Trials

Browse Landscape

Phase

Phase 2 134 Phase 3 79 Phase 1 68 Phase 1/2 31 Phase 2/3 6 Phase NA 5 Phase EARLY_PHASE1 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Thoracic Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Patient Acceptance of Health Care 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Lung Diseases 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Large Cell 1 Cancer Therapy-related Cardiovascular Toxicity 1 Breast Neoplasm Female 1

Interventions

niraparib 4 olaparib 2 apatinib 2 Sevoflurane 2 Saline Solution 2 Propofol 2 Carboplatin 2 Bevacizumab 2 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 pazopanib 1 palbociclib 1 liposomal doxorubicin 1 lenvatinib 1 gadofosveset trisodium 1 fosaprepitant 1 ferrous fumarate 1 Tranexamic Acid 1 Trabectedin 1 Sunitinib 1 Sodium Chloride 1 Pharmacokinetics 1 Patient-Specific Modeling 1 Pafolacianine 1 Paclitaxel 1 LY 353381 1 Injections 1 Indocyanine Green 1 Folic Acid 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Ovarian Neoplasms × Paclitaxel × Clear all

NCT01706120 2023-03-24

MITO16/MANGO-2

National Cancer Institute, Naples

Phase 4 Unknown

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡